Biomark Diagnostics Statistics

Total Valuation

CSE:BUX has a market cap or net worth of CAD 60.66 million. The enterprise value is 60.76 million.

Market Cap	60.66M
Enterprise Value	60.76M

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	105.09M
Shares Outstanding	n/a
Shares Change (YoY)	-84.66%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	12.48%
Owned by Institutions (%)	n/a
Float	48.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	660.94
PB Ratio	119.39
P/TBV Ratio	119.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-35.75
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-29.64

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 2.75.

Current Ratio	1.20
Quick Ratio	1.20
Debt / Equity	2.75
Debt / EBITDA	n/a
Debt / FCF	-0.68
Interest Coverage	-39.96

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-81.70%
Return on Invested Capital (ROIC)	-107.21%
Return on Capital Employed (ROCE)	-218.42%
Weighted Average Cost of Capital (WACC)	3.37%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +177.27% in the last 52 weeks. The beta is -0.16, so CSE:BUX's price volatility has been lower than the market average.

Beta (5Y)	-0.16
52-Week Price Change	+177.27%
50-Day Moving Average	0.51
200-Day Moving Average	0.37
Relative Strength Index (RSI)	63.83
Average Volume (20 Days)	10,629

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:BUX had revenue of CAD 91,771 and -1.70 million in losses. Loss per share was -0.02.

Revenue	91,771
Gross Profit	91,771
Operating Income	-1.97M
Pretax Income	-1.70M
Net Income	-1.70M
EBITDA	-1.95M
EBIT	-1.97M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 1.29 million in cash and 1.40 million in debt, giving a net cash position of -108,839.

Cash & Cash Equivalents	1.29M
Total Debt	1.40M
Net Cash	-108,839
Net Cash Per Share	n/a
Equity (Book Value)	508,033
Book Value Per Share	0.00
Working Capital	243,539

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.42 million and capital expenditures -629,165, giving a free cash flow of -2.05 million.

Operating Cash Flow	-1.42M
Capital Expenditures	-629,165
Free Cash Flow	-2.05M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-2,145.47%
Pretax Margin	-1,852.06%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:BUX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	84.66%
Shareholder Yield	84.66%
Earnings Yield	-2.80%
FCF Yield	-3.38%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2